FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Mamdani Turns Into Kamala Harris on ‘The View’ – Responds With Gibberish to Question on Aides’ Rabid Anti-White Racism

Mexico flies 37 cartel members to US under pressure from Trump admin

Ex-NFL reporter launches GOP Senate bid, reveals how she will flip script on state’s ‘crisis of leadership’

What will Trump’s Greenland obsession mean for the future of NATO?

Davos braces for Trump as even he admits: ‘I have no idea what’s going to happen’

Crime, guns, and taxes: Democrats seek to reshape Virginia moments after taking power

Georgia teen arrested after father turns him in following pair of shootings, police say

Cause of death revealed weeks after woman died following Universal Orlando ride: report

Gov Whitmer says America ‘ready for a woman president,’ contrasting Michelle Obama

Air Force One turns around shortly after takeoff for Trump’s trip to Switzerland

Lindsey Halligan leaves US attorney post after weeks of judicial scrutiny

Former Trump lawyer accuses federal judge of making ‘baseless accusations of lying’ after departure

Missouri couple accused of locking teens in chicken pen, shooting them with BB guns in abuse case

House passes AI education bill for small businesses in landslide 395-14 vote

Cities Church Issues Full-Throated Response to Invasion of their Sunday Worship Service by Leftist Agitators

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”